Home/Filings/4/0001209191-22-008596
4//SEC Filing

Dawson Michael John 4

Accession 0001209191-22-008596

CIK 0001357459other

Filed

Feb 9, 7:00 PM ET

Accepted

Feb 10, 6:40 PM ET

Size

5.6 KB

Accession

0001209191-22-008596

Insider Transaction Report

Form 4
Period: 2021-11-18
Dawson Michael John
Chief Medical Officer
Transactions
  • Award

    Stock Option (right to buy)

    2021-11-18+39,29439,294 total
    Exercise: $2.32Exp: 2031-11-17Common Stock (39,294 underlying)
Footnotes (1)
  • [F1]1/12th of the shares underlying the Stock Option shall vest and become exercisable on each three-month anniversary of the vesting commencement date and if there is no corresponding day, the last day of the month.

Issuer

PALISADE BIO, INC.

CIK 0001357459

Entity typeother

Related Parties

1
  • filerCIK 0001849790

Filing Metadata

Form type
4
Filed
Feb 9, 7:00 PM ET
Accepted
Feb 10, 6:40 PM ET
Size
5.6 KB